ArticleOncotarget2014

Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.

Jan Kroon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.